Meet the Team


Personal Chair

Steve Conlan is Professor of Molecular and Cell Biology at Swansea University Medical School. He is head of the Reproductive Biology and Gynaecological Oncology research group, and Head of Enterprise and Innovation for the Medical School.

Personal Chair

Deya’s research focuses on gene expression and function in the uterus and its relationship to fertility and cancer. Her clinical interests are Polycystic Ovary Syndrome (PCOS), endometriosis, unexplained infertility and gynaecological cancers (endometrial, ovarian and cervical cancer).

Associate Professor

Dr Francis is Associate Professor in the Medical School and leads the groups Biophysics and Epigenetics research programmes. Lewis is an expert in molecular biophysical measurements, and has developed tissue, cell and biochemical research approaches for functional cell and molecular analysis.

Senior Lecturer

Dr Healey specialises in nanomedicine and advanced therapeutic development. He has been extensively involved in the development of novel therapies for asthma, infectious diseases and cancer throughout his career, successfully delivering several multi-institutional, international projects. Gareth is also co-investigator on the CALIN & CEAT projects

Dr Bruna Corradetti

Associate Professor

Bruna Corradetti is Associate Professor at Swansea University Medical School funded by an MSCA COFUND Fellowship and Assistant Research Professor at Houston Methodist Research Institute. Current research focuses on nanotechnology-based approaches to implement immunotherapy for ovarian cancer treatment and immunomodulation for chronic diseases

Clinical Staff and Embryologists

Dr Lavinia Margarit

Consultant Gynaecologist and Obstetrician in Cwm Taff University Health Board.

Honorary Professor, Swansea University Medical School

Dr Paul Knaggs

Embryologist at the Wales Fertility Institute, Swansea Bay University Health Board

Honorary Associate Professor, Swansea University Medical School

Dr Kate Murphy

R&D Lead and Speicalist Biomedical Scientist in Cellular Pathology, Swansea Bay University Health Board.

Working in collaboration with RBGO to develop spacial transcriptomics to profile type 1&2 endometrial cancer.

Postdoctoral Research Associates

RISE Postdoctoral Research Associate

Andrea`s current research activity involves the use of high resolution microscopic techniques and advanced data analysis to investigate the biophysical properties of exosomes and their influence on the role of exosomes as therapeutic effectors.

RISE Postdoctoral Research Associate

Jezabel’s research focuses on the study of novel cancer biomarkers and the development of advanced therapeutics in precision medicine. Her clinical interests are mainly gynaecological (ovarian, endometrial and cervical cancer) and breast cancers.

RISE Postdoctoral Research Associate

Samantha is currently based at ReNeuron, where her current research focuses on exosomes, and their development as a clinical therapeutic as part of the RISE project. Other research interests include the role of stress on female infertility, Polycystic Ovary Syndrome (PCOS), endometriosis, unexplained infertility and gynaecological cancers.

Dr David Howard

ACNM Postdoctoral Research Associate

Through ACNM, David is involved in industry-academia collaborative projects supporting the science industries in East Wales. His research interests lie in the development of targeted therapies for endometrial and ovarian cancers.

Dr Liliana Ordonez

Wales Cancer Research Centre Postdoctoral Research Associate

Liliana's current research focuses on developing Antibody Drug Conjugates against a novel target for patients with ovarian cancer. The project is funded by the Wales Cancer Research Centre. Her research interests involve creating targeted therapeutics for gynaecological and breast cancers, as well as investigating resistance to cancer therapies.

Dr David W James

CEAT Postdoctoral Research Associate

David is a bioinformatician working across all aspects of the CEAT project from identification of potential ADC targets to NGS sequencing analysis. His current research interests involve cell phenotype identification using image analysis and machine learning techniques.

CEAT Postdoctoral Research Associate

Marcos’ current research involves the identification and characterization of novel epigenetic drugs, ascertaining their potential as new routes for ovarian cancer treatment. Dr Quintela has expertise in the epigenetic profiling of ovarian cancer samples; greater understanding of this area will inform and benefit future therapeutic choices.

Dr Lydia Powell

CEAT Postdoctoral Research Associate

Lydia’s main research interests are focused on employing micro- and nanoscale characterisation techniques, such as Atomic Force Microscopy (AFM), to define the interactions of nanomedicines and clinically-relevant surfaces with prokaryotic and eukaryotic systems, thereby informing the design and delivery of novel therapies for life-limiting disease.

Dr Alice Luther

CALIN Postdoctoral Researcher Associate

Alice is the innovation officer in the CALIN project where she is involved in industry-academia collaborative projects supporting the science industries in Wales and Ireland. Her expertise lies in immunotherapy and molecular biology research for precision medicine in gynaecological malignancies.

Dr Emenike Kenechi Onyido

CEAT Postdoctoral Research Associate

Emenike's current research is focused on identifying and evaluating novel Anti-Drug Conjugate targets of ovarian cancer through the application of characterization techniques that enable a more robust assessment of the affinity, tumor penetration, and cell internalization properties of ADCs. Emenike's clinical research interests are centered around gynecological (ovarian, endometrial) as well as colorectal cancer.

Dr Nour Al Abdullah Al Kafri

Honorary Research Fellow

Nour is an honorary research fellow at Swansea University and works with RBGO group. Nour is a Pharmacist with a doctorate degree in molecular biology and has expertise in molecular biology, cancer research and analysis of receptor signalling. During her study she worked at Novartis Pharmaceuticals as a senior product specialist and has 7-years' experience in pharmaceutical services and research.

Dr Fereshteh Izadi

Continuum Postdoctoral Research Associate

Dr Fereshteh Izadi is a post-doctoral researcher working on the continuum project. Fereshteh gained a PhD in molecular genetics during her studies in Iran. Shortly afterwards, Fereshteh did took up a postdoctoral research position in UCL where her research focused on single cell RNA-seq data analysis. Fereshteh also worked on whole genome sequencing data at University of Southampton.

Claire Donnelly

Wales Cancer Research Centre Postdoctoral Research Associate

Claire's research focuses on developing Antibody Drug Conjugates against a novel target for patients with ovarian cancer.

Project Staff

RISE Project Coordinator and CALIN Marketing & Administration Officer

Helen provides administrative support to Prof Steve Conlan and the RBGO team. She also coordinates the RISE project and provides marketing and administrative assistance to the CALIN project.

CEAT Project Officer

In her current role, Zoe works with industrial and clinical partners to facilitate the smooth running of the CEAT project. Zoe's scientific background enables her to contribute to research journals and articles generated through CEAT.

PhD Students

Michael Williams

Swansea University & Houston Methodist Research Institute, Texas, Collaborative PhD

Kadie Edwards

KESS 2 PhD in collaboration with Tenovus Cancer Care

Project: Biodegradable Nanovectors for the Treatment of Advanced Ovarian Cancers

Tasmia Tahsin

KESS2 funded PhD in collaboration with Cardiff Medical School and Betsi Cadwaladr University Health Board ( BCUHB)

Project: Targeting mTORC1 hyperactive cancer cells to get selective cytotoxicity with drugs and further assessing ferroptosis-a novel type of iron-dependant programmed cell death

Francesca Paradiso

PhD program sponsored by Swansea University in collaboration with Dr. Taraballi’s lab at Houston Methodist Research Institute (Houston, TX).

Project: The role of extracellular matrix biochemical and mechanical cues in Ovarian Cancer development.